307b
KIR/HLA Genotypes that Inhibit NK Cell Activation Are Associated with Protection against HIV-1 Disease Progression
Wim Jennes*1, S Verheyden2, C Demanet2, O Tossou3, B Vuylsteke1, and L Kestens1
1Inst of Tropical Med, Antwerp, Belgium; 2Univ Hosp Brussels, Belgium; and 3Project RETRO-CI, Abidjan, Côte d`Ivoire
Background: Individuals with KIR3DS1 in the presence
of HLA-B Bw4-80I show a significant delay in HIV-1 disease progression. The
role of the other KIR genes is less well studied. In this study, we analyzed
the influence of inhibitory and activating KIR genes and their HLA ligands on
markers of HIV-1 disease progression in a population of female sex workers
(FSW) in Abidjan, Côte d'Ivoire.
Methods: We studied 32 HIV-1-seropositive FSW
attending a confidential clinic in Abidjan, Cote d'Ivoire. All subjects were
therapy-naive at the time of sampling. Inhibitory and activating KIR and their
known HLA class I ligand genes were molecularly typed using polymerase chain
reaction (PCR) -SSP and PCR-SSO techniques, respectively. In a cross-sectional
set-up, KIR genotypes and KIR/HLA gene combinations were correlated with the
subjects’ first CD4+ T cell count and HIV-1 plasma viral load result
at the clinic.
Results: FSW with an AA KIR genotype, containing few
activating KIR genes, showed a significantly higher CD4+ T cell
count than FSW with an AB or BB KIR genotype (median values of 626 vs 332
cells/mL; p = 0.001).
Independent from this, FSW who possessed HLA ligand genes for all of their
inhibitory KIR genes showed a significantly higher CD4+ T cell count
than FSW who lacked HLA ligand genes for 1 or more inhibitory KIR genes (median
values of 523 vs 363 cells/mL; p
= 0.036). No such associations were found with HIV-1 plasma viral load levels.
Conclusions: The presence of an AA KIR genotype or
having HLA ligand genes for all inhibitory KIR genes independently predisposes
to higher CD4+ T cell counts among African HIV-1-seropositive FSW.
These KIR/HLA genotypes are predictive for weaker natural killer (NK) cell
activation and stronger NK cell inhibition, respectively, which may protect
against HIV disease progression through inhibition of NK cell-mediated killing
of CD4+ T cells.
|